KELOWNA, BC / ACCESSWIRE / May 20, 2015 / Lexaria Corp. (LXRP) (CSE:LXX) (the "Company") is pleased to announce it has engaged Absorption Systems LP in the USA, to begin third party in vitro tests ...

Being able to predict the amount of medicine that, once taken orally, effectively reaches the blood circulation is one of the most pressing issues in drug development. Now, researchers have turned to ...

Dublin, Nov. 05, 2025 (GLOBE NEWSWIRE) -- The "Dissolution Testing in Pharma - From Development to Regulatory Approval" training has been added to ResearchAndMarkets.com's offering. Dissolution ...

When it comes to dissolution testing, research is focusing on ways to extend its reach, improve in-vitro and in-vivo correlation, and make real-time release testing a reality. Studying how a drug ...

Researchers have for the first time shown that reduced vitamin D absorption in patients with quiescent Crohn's disease may be the cause for their increased risk for vitamin D deficiency. The findings ...

PureTech Health has cleared an early hurdle in its pursuit of Sage Therapeutics, linking its oral prodrug of allopregnanolone to a nine-fold increase in the blood levels achieved by the unmodified ...

Scolr Pharma Inc. has commenced pilot bioavailability testing in Canada of its immediate release CDT-fenofibrate tablets. Results from the trial are expected in late 2007. Authorized by the ...